Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis

被引:90
|
作者
Mewar, Devesh
Coote, Annabel
Moore, David J.
Marinou, Ioanna
Keyworth, Jodie
Dickson, Marion C.
Montgomery, Doug S.
Binks, Michael H.
Wilson, Anthony G. [1 ]
机构
[1] Univ Sheffield, Div Genom Med, Sheffield, S Yorkshire, England
[2] GlaxoSmithKline R&D, Stevenage, Herts, England
关键词
D O I
10.1186/ar2017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Several recent publications have established a strong association between anti-cyclic citrullinated peptide antibody (anti-CCP)-positive rheumatoid arthritis ( RA) and carriage of shared epitope ( SE) alleles. Although anti-CCP have also been associated with more severe RA, the issue of whether this is independent of rheumatoid factor (RF) has not been addressed. To identify associations between RF, anti-CCP, SE status and radiological damage, we studied a large cross- sectional cohort with longstanding RA. Individuals (n = 872) enrolled in the study all fulfilled the American College of Rheumatology criteria for RA, had a minimum disease duration of 3 years, and at least one definite radiographic erosion was present in hands or feet. Radiographs were scored blind at study entry by a single musculoskeletal radiologist using a modified Larsen's score. Anti-CCP and RF levels were determined using enzyme-linked immunosorbent assay, and DRB1 typing was performed using polymerase chain reaction based methodology. Both anti-CCP and RF levels were strongly associated with radiographic severity ( P < 0.0001). In subgroups stratified for both anti-CCP and RF status, evidence of independent associations of both antibodies with radiographic outcome was found ( P < 0.0001). An association of SE alleles with radiographic severity was present only in RF-negative individuals. Anti-CCP positivity was associated with SE status with evidence of a gene-dose effect, most markedly in RF-negative individuals ( P < 0.01). Anti-CCP and RF status are independent severity factors for RA, with SE alleles playing at most a secondary role. Our data support the view that previously described associations between SE and radiological severity, especially in RF-negative patients, may be indirect and due to an association with anti-CCP.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis
    Devesh Mewar
    Annabel Coote
    David J Moore
    Ioanna Marinou
    Jodie Keyworth
    Marion C Dickson
    Doug S Montgomery
    Michael H Binks
    Anthony G Wilson
    Arthritis Research & Therapy, 8
  • [2] The effect of etanercept on anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis
    Chen, HA
    Lin, KC
    Chen, CH
    Liao, HT
    Wang, HP
    Chang, HN
    Tsai, CY
    Chou, CT
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (01) : 35 - 39
  • [3] Anti-cyclic citrullinated peptide antibodies in advanced rheumatoid arthritis
    Pinheiro, GC
    Scheinberg, MA
    da Silva, MA
    Maciel, S
    ANNALS OF INTERNAL MEDICINE, 2003, 139 (03) : 234 - 235
  • [4] Are anti-cyclic citrullinated peptide antibodies pathogenic in rheumatoid arthritis?
    Holers, V. Michael
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2006, 2 (08): : 400 - 401
  • [5] Are anti-cyclic citrullinated peptide antibodies pathogenic in rheumatoid arthritis?
    V Michael Holers
    Nature Clinical Practice Rheumatology, 2006, 2 : 400 - 401
  • [6] Prognostic value of anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis
    Kuru, Omer
    Bilgici, Ayhan
    Birinci, Asuman
    Ulusoy, Hasan
    Durupinar, Belma
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2009, 110 (10): : 650 - 654
  • [7] Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis
    De Rycke, L
    Verhelst, X
    Kruithof, E
    Van den Bosch, F
    Hoffman, IEA
    Veys, EM
    De Keyser, F
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (02) : 299 - 302
  • [8] Anti-Cyclic Citrullinated Peptide Antibodies and Severity of Interstitial Lung Disease with Rheumatoid Arthritis
    Yamasaki, Masaomi
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [9] RHEUMATOID FACTOR IGA AND ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES: PREDICTORS OF RADIOGRAPHIC PROGRESSION
    Dahanayake, Chanaka
    Ma, Margaret H.
    Scott, Ian C.
    Kingsley, Gabrielle H.
    Cope, Andrew
    Scott, David L.
    RHEUMATOLOGY, 2013, 52 : 69 - 69
  • [10] Comparison of the anti-cyclic citrullinated peptide and rheumatoid factor in rheumatoid arthritis at an arthritis center
    Attar, Suzan M.
    Bunting, Peter S.
    Smith, Charles D.
    Karsh, Jacob
    SAUDI MEDICAL JOURNAL, 2009, 30 (03) : 446 - 447